Blueprint Medicines Corporation (BPMC)
Jul 18, 2025 - BPMC was delisted (reason: acquired by SNY)
129.46
0.00 (0.00%)
Inactive · Last trade price on Jul 17, 2025
Blueprint Medicines Analyst Ratings
Total Analysts
18
Consensus Rating
Buy
Price Target
$128.87
Upside
-0.46%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $143 → $129 | Buy → Hold | Downgrades | $143 → $129 | -0.36% | Jun 17, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $102 → $129 | Hold | Maintains | $102 → $129 | -0.36% | Jun 5, 2025 |
| UBS | UBS | Hold Maintains $88 → $129 | Hold | Maintains | $88 → $129 | -0.36% | Jun 5, 2025 |
| Citigroup | Citigroup | Strong Sell → Hold Upgrades $83 → $129 | Strong Sell → Hold | Upgrades | $83 → $129 | -0.36% | Jun 4, 2025 |
| JMP Securities | JMP Securities | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jun 3, 2025 |
| Stephens & Co. | Stephens & Co. | Buy → Hold Downgrades $150 → $135 | Buy → Hold | Downgrades | $150 → $135 | +4.28% | Jun 3, 2025 |
| Wolfe Research | Wolfe Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jun 3, 2025 |
| Scotiabank | Scotiabank | Buy → Hold Downgrades $135 | Buy → Hold | Downgrades | $135 | +4.28% | Jun 2, 2025 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades $130 → $129 | Buy → Hold | Downgrades | $130 → $129 | -0.36% | Jun 2, 2025 |
| Wedbush | Wedbush | Buy → Hold Downgrades $128 → $129 | Buy → Hold | Downgrades | $128 → $129 | -0.36% | Jun 2, 2025 |
| Needham | Needham | Strong Buy → Hold Downgrades $130 | Strong Buy → Hold | Downgrades | $130 | +0.42% | Jun 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $135 | Strong Buy | Reiterates | $135 | +4.28% | May 2, 2025 |
| Needham | Needham | Strong Buy Maintains $133 → $130 | Strong Buy | Maintains | $133 → $130 | +0.42% | Apr 28, 2025 |
| Wedbush | Wedbush | Buy Reiterates $128 | Buy | Reiterates | $128 | -1.13% | Apr 16, 2025 |
| Needham | Needham | Strong Buy Reiterates $133 | Strong Buy | Reiterates | $133 | +2.73% | Apr 8, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Initiates $120 → $100 | Hold | Initiates | $120 → $100 | -22.76% | Mar 20, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.